Unique presentations of epidermal growth factor receptor inhibitor-induced papulopustular eruption related to bacterial superinfection
- PMID: 23552005
Unique presentations of epidermal growth factor receptor inhibitor-induced papulopustular eruption related to bacterial superinfection
Abstract
Epidermal growth factor receptor (EGFR) inhibitors have been reported to induce numerous cutaneous side effects, the most notable of which is a papulopustular eruption on the face, scalp, and central chest. The typical presentation consists of inflamed papules, often with pustules, favoring a seborrheic distribution. The pustules of the EGFR inhibitor-induced papulopustular eruption are commonly sterile but bacterial superinfection is not uncommon. We report two unique presentations of the papulopustular eruption that were found to be associated with Staphylococcus aureus superinfection. One patient presented with an abrupt onset of nearly confluent red plaques on the cheeks, forehead, chin, and neck, with innumerable studded pinpoint pustules. The other patient had a long-standing untreated papulopustular eruption on the scalp, which resulted in widespread erythema, large thick plaques of serous crust, pustular exudate, and associated alopecia. Both patients quickly resolved with non-tetracycline oral antibiotics combined with topical steroid treatment.
Similar articles
-
EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections.Support Care Cancer. 2016 Sep;24(9):3943-50. doi: 10.1007/s00520-016-3231-1. Epub 2016 Apr 27. Support Care Cancer. 2016. PMID: 27117557
-
Pimecrolimus cream 1% for the treatment of papulopustular eruption related to epidermal growth factor receptor inhibitors: a case series and a literature review of therapeutic approaches.Dermatology. 2010;220(3):243-8. doi: 10.1159/000277430. Epub 2010 Jan 22. Dermatology. 2010. PMID: 20110632 Review.
-
Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.Dermatol Online J. 2007 Jan 27;13(1):1. Dermatol Online J. 2007. PMID: 17511934
-
Cetuximab-induced crusted pustular eruption with patchy alopecia.Dermatol Online J. 2014 Oct 15;20(10):13030/qt0xp3r74p. Dermatol Online J. 2014. PMID: 25526010
-
Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors.Dermatology. 2012;225(1):18-21. doi: 10.1159/000341528. Epub 2012 Aug 22. Dermatology. 2012. PMID: 22922680 Review.
Cited by
-
Successful treatment of epidermal growth factor receptor inhibitor-induced alopecia with doxycycline.JAAD Case Rep. 2015 Jul 30;1(5):289-91. doi: 10.1016/j.jdcr.2015.06.013. eCollection 2015 Sep. JAAD Case Rep. 2015. PMID: 27051756 Free PMC article. No abstract available.
-
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review.Clin Colorectal Cancer. 2018 Jun;17(2):85-96. doi: 10.1016/j.clcc.2017.12.004. Epub 2017 Dec 13. Clin Colorectal Cancer. 2018. PMID: 29576427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous